Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659)
脾酪氨酸激酶/FMS样酪氨酸激酶-3抑制剂治疗复发/难治性B细胞淋巴瘤（包括弥漫性大B细胞淋巴瘤）：mivavotinib（TAK-659/CB-659）的最新数据
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28352
Gordon, Leo I; Karmali, Reem; Kaplan, Jason B; Popat, Rakesh; Burris, Howard A 3rd; Ferrari, Silvia; Madan, Sumit; Patel, Manish R; Gritti, Giuseppe; El-Sharkawi, Dima; Chau, F Ian; Radford, John; de Oteyza, Jaime Pérez; Zinzani, Pier Luigi; Iyer, Swaminathan P; Townsend, William; Miao, Harry; Proscurshim, Igor; Wang, Shining; Katyayan, Shilpi; Yuan, Ying; Zhu, Jiaxi; Stumpo, Kate; Shou, Yaping; Carpio, Cecilia; Bosch, Francesc
B细胞
信号转导
淋巴瘤
多发性硬化症
细胞生物学
免疫/内分泌
